COPD

December 8, 2014November 11, 2015

Study Notes Health, Social Impacts of Under-Diagnosed COPD

COPD, News

A new study from an Italian research team was published this week in the journal Multidisciplinary Respiratory Medicine. The study, entitled “Health and social impacts of COPD and the problem of ... Read more

December 5, 2014November 11, 2015

Observational Arterial Pressure Monitoring Includes COPD Parameters

COPD, News

A new study entitled “Accuracy of invasive arterial pressure monitoring in cardiovascular patients: an observational study” was published in Critical Care by Dr. Stefano Romagnoli, part of Dr. A Raffaele ... Read more

December 5, 2014November 11, 2015

Persistent Eosinophilia Present in COPD Could Improve Patient Outcomes

COPD, News

A recent study entitled “Eosinophilic inflammation in COPD: prevalence and clinical characteristics” reports that patients with chronic obstructive pulmonary disease can have persistent eosinophilia, and that this feature is associated with ... Read more

December 4, 2014November 11, 2015

New COPD Studies Needed To Determine Effects of Reduced Physical Capacity on Patient Outcomes

COPD, News

A new review entitled “Determinants and outcomes of physical activity in patients with COPD: a systematic review” summarizes data from recent studies on the role of physical activity in patient ... Read more

December 3, 2014November 11, 2015

COPD, Asthma Treatment Aided By Computerized Clinical Decision Support Systems

COPD, News

A new review study entitled “Effectiveness of computerized clinical decision support systems for asthma and chronic obstructive pulmonary disease in primary care: a systematic review” summarizes the impact of Computerized ... Read more

December 3, 2014November 11, 2015

Lung Therapeutics Empyema Treatment Receives Orphan Drug Designation

COPD, News

Austin-based Lung Therapeutics, Inc., a pharmaceutical company developing treatments for niche lung diseases, has just announced that the US Food and Drug Administration has granted an Orphan Drug Designation for LTI-01, an ... Read more

December 2, 2014November 11, 2015

Positive Data For Drug That Treats Treatment-Refractory Chronic Cough

COPD, News

A new publication from Afferent Pharmaceuticals’ Phase 2 clinical trial results entitled “P2X3 Receptor Antagonist (AF-219) in Refractory Chronic Cough: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study” was published in ... Read more

December 1, 2014November 11, 2015

Michigan Instruments Donates Respiratory Simulation Training and Test Lung Devices to Michigan Universities

COPD, News

Respiratory therapy students at Michigan’s Grand Valley State University in Allentown, MI and Muskegon Community College in Muskegon will soon have the opportunity to simulate proper management of life-like respiratory ... Read more

December 1, 2014November 11, 2015

BARDA Grants $16 Million to Develop Cempra’s Antibiotic Solithromycin

COPD, News

The Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services has announced that it will provide a $16 million dollar grant to clinical-stage pharmaceutical ... Read more

November 28, 2014November 11, 2015

European Union Approves New Chronic Obstructive Pulmonary Disease Drug

COPD, News

AstraZeneca announced that the European Commission granted their lead drug, Duaklir® Genuair®, marketing authorization as a maintenance bronchodilator treatment for adult patients with chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease (COPD) ... Read more